Da An Gene shareholders approve key governance revisions

Guangzhou Da An Gene Co., Ltd. held its third extraordinary general meeting of shareholders for 2025 on September 15, 2025, where shareholders approved several key proposals. The meeting, held in a hybrid format, saw a total of 723 shareholders and their proxies representing 461,356,913 shares, or 32.8732% of the company's total shares. All proposals were passed without any rejections.

A significant outcome was the approval of revisions to the "Company Articles of Association" and related industrial and commercial registration procedures. This resolution passed with 450,940,523 votes in favor, representing 97.7422% of the voting shares present, with 10,217,997 votes against and 198,393 abstentions. This particular resolution required a two-thirds majority and was successfully carried.

Further, shareholders approved amendments to the "Rules of Procedure for the Board of Directors" and the "Rules of Procedure for Shareholder Meetings." The "Rules of Procedure for the Board of Directors" amendment garnered 451,794,639 votes (97.9274% in favor), while the "Rules of Procedure for Shareholder Meetings" amendment received 451,805,532 votes (97.9297% in favor). Both amendments, also classified as special resolutions, successfully passed with the required two-thirds majority.